Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act ("Report on Wearable Medical Devices")
Mandates the Comptroller General to conduct a technology assessment of wearable medical devices within 18 months of the Act's enactment. Requires submission of a report to Congress on the capabilities and limitations of these devices in supporting clinical decision-making. Includes a description of the potential for wearable devices to accurately prescribe treatments. Examines the benefits and challenges of using artificial intelligence to augment these capabilities. Suggests policy options to enhance the benefits and address the challenges of developing or using wearable medical devices.
Paper
Full text
Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act ("Report on Wearable Medical Devices")
ETO AGORA · U.S. federal laws · 2024
Summary
Mandates the Comptroller General to conduct a technology assessment of wearable medical devices within 18 months of the Act's enactment.
Requires submission of a report to Congress on the capabilities and limitations of these devices in supporting clinical decision-making.
Includes a description of the potential for wearable devices to accurately prescribe treatments.
Examines the benefits and challenges of using artificial intelligence to augment these capabilities.
Suggests policy options to enhance the benefits and address the challenges of developing or using wearable medical devices.
Requires the Comptroller General to report on wearable medical devices' capabilities and AI augmentation benefits.
SEC. 217. REPORT ON WEARABLE MEDICAL DEVICES.
Not later than 18 months after the date of the enactment of this Act, the Comptroller General of the United States shall conduct a technology assessment of, and submit to Congress a report on, the capabilities and limitations of wearable medical devices used to support clinical decision-making. Such report shall include a description of-- (1) the potential for such devices to accurately prescribe treatments; (2) an examination of the benefits and challenges of artificial intelligence to augment such capabilities; and (3) policy options to enhance the benefits and mitigate potential challenges of developing or using such devices.